SEC Tracker
Get the app
BIAF · XBRL financial data

bioAffinity Technologies financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BIAF's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue3007,579*——————————
Revenue from contracts with customers298year only2,4062,3982,3502,208*1,8541,2691,4461,593*1,3521,511
Cost of revenue75———————————
Gross profit224———————————
Research and development330433*394402274391*367311331374*350362
Selling, general and administrative2,0242,214*2,1862,4732,3652,920*2,4532,2152,2093,037*3,2422,859
Total operating expenses2,5184,632*4,3524,4854,3245,154*4,4813,7853,7394,730*4,9694,845
Operating income (loss)(2,295)(2,342)*(1,945)(2,088)(1,974)(2,947)*(2,627)(2,516)(2,293)(3,137)*(3,617)(3,335)
Interest income2712*6524*12120*103
Interest expense925*24222225*1510513*1512
Other income (expense)——50————————
Income tax expense (benefit)22*4530*92933*——
Net income (loss)(2,291)(2,373)*(1,962)(2,110)(2,001)(2,967)*(2,660)(4,061)(5,051)(3,137)*(3,631)(3,366)
Earnings per share, basic USD per share(0.26)(0.25)*(0.20)(0.19)(0.16)(0.20)*(0.16)(0.17)(4.74)—(0.81)(0.64)
Earnings per share, diluted USD per share(0.26)(0.25)*(0.20)(0.19)(0.16)(0.20)*(0.16)(0.17)(4.74)—(0.81)(0.64)
Weighted average shares, basic thousands of shares8,6979,330*9,91511,38912,39214,772*16,25724,0221,066—4,4955,227
Weighted average shares, diluted thousands of shares8,6979,330*9,91511,38912,39214,772*16,25724,0221,066—4,4955,227

Balance sheet

CSV

Fiscal quarters (BIAF's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents4,5092,8222,4538017571,1054458037,6696,4503,0982,430
Inventory10189302528394435547882
Prepaid and other current assets383321345254440423417400460520480458
Total current assets6,0103,9733,9312,6802,5492,6951,8641,6698,6147,5654,3413,865
Property and equipment, net512459461449418375382351303266247314
Right-of-use asset392370348325494463432400367334651769
Goodwill1,1491,4041,4041,4041,4041,4041,4041,4041,4041,4041,4041,404
Total assets10,1898,2228,0496,6566,5526,5145,5474,75111,54610,9617,9457,619
Accounts payable8276053848487839871,3821,170941762836970
Accrued liabilities6441,1508839699041,3991,3711,0489851,7182,0341,414
Total current liabilities1,9592,2481,7722,3262,4913,1053,4152,5882,3602,9063,1852,681
Lease liability, non-current307283258233375342308274239203545638
Total liabilities3,1963,3662,7923,2233,4313,9124,1086,8872,6443,6834,2843,850
Accumulated deficit(42,231)(44,604)(46,566)(48,677)(50,677)(53,644)(56,305)(60,366)(65,417)(68,554)(72,185)(75,551)
Total stockholders' equity6,9944,8555,2573,4333,1212,6021,439(2,136)8,9027,2783,6613,769
Total liabilities and equity10,1898,2228,0496,6566,5526,5145,5474,75111,54610,9617,9457,619
Common shares outstanding (cover page) thousands of shares9,50211,51411,65813,44915,58518,25627,24928,4694,4994,4994,5358,102

Cash flows

CSV

Fiscal quarters (BIAF's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(2,291)(2,373)*(1,962)(2,110)(2,001)(2,967)*(2,660)(4,061)(5,051)(3,137)*(3,631)(3,366)
Stock-based compensation186*235*284286*186*234*327212*67*66*14785*
Net cash from operating activities(1,533)*(1,616)*(2,346)(1,532)*(1,709)*(1,677)*(1,642)(2,647)*(2,480)*(2,560)*(3,227)(3,201)*
Purchases of property and equipment0*(13)*4128*9*0*5113*(4)*0*690*
Net cash from investing activities(2,187)*13*(41)(28)*(9)*(0)*(51)(13)*4*(0)*(6)(90)*
Proceeds from issuing common stock—————————0*0*0*
Net cash from financing activities(51)*(85)*2,019(91)*1,674*2,026*1,0323,019*9,343*1,340*(119)2,622*
Net change in cash(3,770)*(1,688)*(368)(1,652)*(45)*349*(661)358*6,866*(1,219)*(3,351)(669)*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
bioAffinity Technologies2,4301,511(3,201)*8.1M0.8 quarters 10-QJun 30, 2026
IB Acquisition30not reported(474)*5.0M0.1 quarters 10-QJun 30, 2026
OneMedNet358292(1,875)*59.3M0.2 quarters 10-QJun 30, 2026
20/20 Biolabs4,546731(605)*12.8M7.5 quarters 10-QJun 30, 2026
Inotiv15,180117,652(1,070)*34.9M14.2 quarters 10-QMar 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.